<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">782333</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2021.782333</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Recent Trends in Biofabrication Technologies for Studying Skeletal Muscle Tissue-Related Diseases</article-title>
<alt-title alt-title-type="left-running-head">Cho and Jang</alt-title>
<alt-title alt-title-type="right-running-head">Biofabrication of Muscle Disease Models</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Seungyeun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1276259/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jang</surname>
<given-names>Jinah</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/858749/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Department of Convergence IT Engineering, Pohang University of Science and Technology, <addr-line>Pohang</addr-line>, <country>South Korea</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, <addr-line>Pohang</addr-line>, <country>South Korea</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Department of Mechanical Engineering, Pohang University of Science and Technology, <addr-line>Pohang</addr-line>, <country>South Korea</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Institute for Convergence Research and Education in Advanced Technology, Yonsei University, <addr-line>Seoul</addr-line>, <country>South Korea</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1090192/overview">Farnaz Ghorbani</ext-link>, University of Erlangen Nuremberg, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/834129/overview">Wanling Xuan</ext-link>, Augusta University, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/476547/overview">Francesco Chemello</ext-link>, University of Texas Southwestern Medical Center, United&#x20;States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jinah Jang, <email>jinahjang@postech.ac.kr</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>782333</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>10</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Cho and Jang.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Cho and Jang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>In native skeletal muscle, densely packed myofibers exist in close contact with surrounding motor neurons and blood vessels, which are embedded in the fibrous connective tissue. In comparison to conventional two-dimensional (2D) cultures, the three-dimensional (3D) engineered skeletal muscle models allow structural and mechanical resemblance with native skeletal muscle tissue by providing geometric confinement and physiological matrix stiffness to the cells. In addition, various external stimuli applied to these models enhance muscle maturation along with cell&#x2013;cell and cell&#x2013;extracellular matrix interaction. Therefore, 3D <italic>in&#x20;vitro</italic> muscle models can adequately recapitulate the pathophysiologic events occurring in tissue&#x2013;tissue interfaces inside the native skeletal muscle such as neuromuscular junction. Moreover, 3D muscle models can induce pathological phenotype of human muscle dystrophies such as Duchenne muscular dystrophy by incorporating patient-derived induced pluripotent stem cells and human primary cells. In this review, we discuss the current biofabrication technologies for modeling various skeletal muscle tissue-related diseases (i.e.,&#x20;muscle diseases) including muscular dystrophies and inflammatory muscle diseases. In particular, these approaches would enable the discovery of novel phenotypic markers and the mechanism study of human muscle diseases with genetic mutations.</p>
</abstract>
<kwd-group>
<kwd>disease modelling</kwd>
<kwd>hiPSC</kwd>
<kwd>extrusion printing</kwd>
<kwd>volumetric muscle loss</kwd>
<kwd>muscular dystrophy</kwd>
<kwd>self-repair</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Research Foundation of Korea<named-content content-type="fundref-id">10.13039/501100003725</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Skeletal muscles constitute 35&#x2013;40% of the human body weight and are essential for maintaining the posture, locomotion, and respiration of the human body. The tissue microenvironment comprises uniaxially aligned multinucleated muscle cells (myofibers) that are arranged in a three-dimensional (3D) extracellular matrix (ECM) scaffold. Owing to the presence of muscle-resident stem cells, also referred as satellite cells (SCs), the healthy skeletal muscles exhibit an inherent capacity for regeneration in response to small-scale injuries. However, the muscular self-repair mechanism is hindered by traumatic or surgical injuries, genetic mutations in ECM and sarcolemmal proteins, neurodegenerative diseases, aging-induced alterations in ECM compositions, regulatory cell behaviors, and signaling pathways that result in a wide range of diseases (<xref ref-type="bibr" rid="B78">Relaix et&#x20;al., 2021</xref>).</p>
<p>In context, Duchenne muscular dystrophy (DMD) is a notable progressive muscle-wasting disease that results from failed production of dystrophin&#x2014;a protein that stabilizes the myofibers. Although several antisense oligonucleotide-mediated exon-skipping therapies including eteplirsen, golodirsen, and viltolarsen treatment were granted conditional approval by the United&#x20;States Food and Drug Administration (FDA), no current cure exists for the DMD (<xref ref-type="bibr" rid="B10">Bursac et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B4">Alfano et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B16">Clemens et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B26">Frank et&#x20;al., 2020</xref>). Charcot&#x2013;Marie&#x2013;Tooth disease (CMT) is the most commonly inherited neuromuscular disorder that causes distal muscle atrophy and results in a high-arched foot, impaired gait, and frequent falls. Although PXT3003&#x2014;a drug that downregulates PMP22 mRNA expression&#x2014;entered phase III of clinical trials in 2021, no clinically approved therapies currently exist for CMT (<xref ref-type="bibr" rid="B86">Vallat et&#x20;al., 2013</xref>).</p>
<p>Genetically engineered mice lacking dystrophin and/or utrophin (a homolog of dystrophin) have been utilized to study the mechanism of DMD. Dystrophin-deficient mdx mice recapitulate mild dystrophic phenotypes. Compared with dog models and affected humans, mdx mice cannot model more severe disease phenotypes such as limb muscle fibrosis (<xref ref-type="bibr" rid="B64">McGreevy et&#x20;al., 2015</xref>). However, dystrophin&#x2013;utrophin double knockout (dko) mice (i.e.,&#x20;dko model) have been suggested as a more useful model to study the disease, as utrophin can compensate for the absence of dystrophin (<xref ref-type="bibr" rid="B90">Grady et&#x20;al., 1997</xref>). Notably, a wide spectrum of degenerative musculoskeletal abnormalities has been reported using dko model (<xref ref-type="bibr" rid="B38">Isaac et&#x20;al., 2012</xref>). However, this additional mutation in another gene, excluding dystrophin, does not correlate with the case in affected humans (<xref ref-type="bibr" rid="B64">McGreevy et&#x20;al., 2015</xref>).</p>
<p>This genetic discrepancy has adversely affected the correct prediction of drug responses, as exemplified by the market withdrawal of cerivastatin, which caused fatal myopathies in human but was well-tolerated in mice (<xref ref-type="bibr" rid="B28">Furberg and Pitt et&#x20;al., 2001</xref>). Although Idebenone apparently reduced the cardiac inflammation and fibrosis in a preclinical study with mdx mice, the phase III of the clinical trials assessing its capacity on delaying the respiratory decline in DMD patients was ceased in October 2020 after failing an interim analysis (<xref ref-type="bibr" rid="B11">Buyse et&#x20;al., 2009</xref>). Thus, a preclinical human muscle tissue-related disease model is required to be developed to accurately mimic human pathophenotypes and disease progressions.</p>
<p>In context, complex biomimetic skeletal muscle structures have been developed using numerous biofabrication technologies that support the growth and maturation of cells in a 3D arrangement. Lithography-based methods and microfluidic devices have been utilized on micropattern surfaces with aligned topographical features (e.g., grooves) onto which seeded cells were directed to uniaxially align and differentiate into myofiber-like structures. Recent advancements in biofabrication methods such as 3D printing technology and electrospinning have yielded 3D tissue-engineered muscle models with multiscale structural cues resembling the hierarchical tissue geometry.</p>
<p>Physiologically relevant skeletal muscle phenotypes were obtained by placing endothelial, stromal, and neural cells in contact with myofibers, which could more precisely mimic the paracrine interactions occurring in the native tissue. In addition, the cell&#x2013;matrix interaction that influences force transmission in native myofibers were also modeled. By contrast, conventional 2D models such as monoculture cellular assays are limited in recapitulating complex tissue architectures such as hierarchical arrangement. In addition, 2D models have limited capacity for muscle maturation, as contracting myofibers detach from the substrate, whereas 3D models support spontaneous cell fusion and myofiber enlargement (which resembles muscle hypertrophy) throughout several weeks of culture. Based on these advantages of the 3D models, a wide range of human muscle diseases have been recapitulated &#x201c;in a dish.&#x201d; In addition, the incorporation of human-induced pluripotent stem cells (hiPSCs) enables the recapitulation of patient-specific disease phenotypes in these models.</p>
<p>In this review, we discuss the biomaterials widely utilized as 3D scaffold materials for muscle cells, followed by a review of multiple biofabrication technologies that yield aligned myofibers within the aforementioned biomaterials, such as shear/tensile force, aligned geometrical cues, and 3D bioprinting skills that allow deposition of cell-laden hydrogels in a desired geometry. Subsequently, we address the recent examples of vascularization, innervation, and electrical/mechanical stimuli that allowed additional maturation of 3D-engineered muscle. Ultimately, we highlight the application of these techniques for human muscle tissue-related disease modeling (i.e.,&#x20;muscular dystrophies and inflammatory muscle diseases).</p>
</sec>
<sec id="s2">
<title>Biomaterials Utilized in 3D Tissue-Engineered Muscle</title>
<p>In conventional 2D cultures, the mechanical properties of the rigid tissue culture substrates do not correspond to those of the native skeletal muscle tissue, which results in developmentally immature myotube structures such as poor striations and premyofibril myosin organization (<xref ref-type="bibr" rid="B24">Engler et&#x20;al., 2004</xref>). Instead, several natural polymers have been proposed as a scaffold material to culture muscle cells in a 3D environment. In this section, we reviewed multiple biomaterials that are frequently used in fabricating 3D-engineered muscle, such as collagen, fibrin, and decellularized extracellular matrix (dECM) (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). In addition, Matrigel, which is a basement membrane extract originating from Engelbreth&#x2013;Holm&#x2013;Swarm (EHS) sarcoma and is rich in ECM proteins such as laminin and collagen IV, has been used in combination with collagen and fibrin.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Different types of biomaterials used in skeletal muscle tissue engineering.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Biomaterials</th>
<th align="center">Pros/Cons</th>
<th align="center">Achievement</th>
<th align="center">Relevant bioactivities</th>
<th align="center">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">Collagen</td>
<td rowspan="3" align="left">Structural cues/low remodeling capacity</td>
<td align="left">Uniaxial cell alignment</td>
<td align="left">Fibril bundle formation</td>
<td align="left">Kim and Kim et&#x20;al. (<xref ref-type="bibr" rid="B51">2019</xref>)</td>
</tr>
<tr>
<td rowspan="2" align="left">Long-term construct stability</td>
<td align="left">Cell attachment</td>
<td rowspan="2" align="left">Morimoto et&#x20;al. (<xref ref-type="bibr" rid="B67">2020</xref>)</td>
</tr>
<tr>
<td align="left">Large pore size</td>
</tr>
<tr>
<td rowspan="2" align="left">Fibrin</td>
<td rowspan="2" align="left">High contractile force/batch-to-batch variability</td>
<td align="left">Human fetus-relevant force production</td>
<td align="left">Native tissue stiffness</td>
<td align="left">Hinds et&#x20;al. (<xref ref-type="bibr" rid="B34">2011</xref>)</td>
</tr>
<tr>
<td align="left">High myofiber and vascular density after implantation</td>
<td align="left">Pro-angiogenic effect</td>
<td align="left">Gilbert-Honick et&#x20;al. (<xref ref-type="bibr" rid="B32">2018</xref>)</td>
</tr>
<tr>
<td align="left">Laminin</td>
<td align="left">Cell attachment/degradation</td>
<td align="left">Dose-dependent increase in cell proliferation</td>
<td align="left">&#x3b1;7&#x3b2;1 integrin expression</td>
<td align="left">Marcinczyk et&#x20;al. (<xref ref-type="bibr" rid="B62">2017</xref>)</td>
</tr>
<tr>
<td align="left">dECM</td>
<td align="left">Biochemical and structural cues/low structural stability</td>
<td align="left">
<italic>In vitro</italic> AChR cluster formation</td>
<td align="left">Presence of agrin</td>
<td align="left">Choi et&#x20;al. (<xref ref-type="bibr" rid="B14">2016</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Collagen is an abundant component of the ECM in native muscle tissue that was utilized in the earliest cases of 3D-engineered muscle (<xref ref-type="bibr" rid="B74">Powell et&#x20;al., 2002</xref>). <xref ref-type="bibr" rid="B74">Powell et&#x20;al. (2002)</xref> observed that human primary muscle cells embedded in collagen/Matrigel mixture formed parallel arrays of differentiated myofibers under passive tension. However, the absence of collagen I-specific integrin in myotubes resulted in lesser contractility than that of the other types of integrin-binding ECM proteins such as fibrin and laminin (<xref ref-type="bibr" rid="B63">Mayer, 2003</xref>). Therefore, increasing the concentration of collagen could adversely affect the force generation (<xref ref-type="bibr" rid="B34">Hinds et&#x20;al., 2011</xref>). In another research, <xref ref-type="bibr" rid="B22">Dixon et&#x20;al. (2018)</xref> prepared a collagen/Matrigel/silk hydrogel that successfully induced myogenic differentiation, maintained its mechanical integrity during the compacting around silk cantilevers, and formed a 3D-engineered muscle (<xref ref-type="bibr" rid="B22">Dixon et&#x20;al., 2018</xref>).</p>
<p>Fibrin is the fundamental component of a blood clot that is formed in the initial steps of the wound-healing process, and subsequently, replaced by the cell-produced ECM. Upon using in skeletal muscle tissue engineering, fibrin can exert a passive stiffness that is several orders of magnitude lower than that of collagen and comparable to that of native skeletal muscle. <xref ref-type="bibr" rid="B60">Madden et&#x20;al. (2015)</xref> demonstrated tetanus force production that corresponded to that of the fetal human skeletal muscle in a fibrin-based 3D-engineered muscle. In addition, fibrin often prevents tissue deformation under tissue remodeling owing to its capacity to be degraded and replaced by endogenous ECM. <xref ref-type="bibr" rid="B15">Christensen et&#x20;al. (2020)</xref> fabricated a contractile muscle tissue with fibrin/Matrigel, which was anchored to two cantilevers and maintained the tissue confined during cell-mediated compaction. Thus, the fibrin can support the spontaneous formation of contractile myotubes (<xref ref-type="bibr" rid="B60">Madden et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B15">Christensen et&#x20;al., 2020</xref>).</p>
<p>Lastly, dECM has emerged as a potential candidate for inducing the elongation and fusion of muscle cells owing to its tissue-specific cell-binding moieties, ECM topography, and physical ultrastructures. Furthermore, studies have demonstrated that dECM could induce tissue-specific cell differentiation (<xref ref-type="bibr" rid="B25">Flynn, 2010</xref>; <xref ref-type="bibr" rid="B85">Uygun et&#x20;al., 2010</xref>). <xref ref-type="bibr" rid="B14">Choi et&#x20;al. (2016)</xref> developed the preparation process of skeletal muscle decellularized extracellular matrix (mdECM). Notably, agrin&#x2014;an ECM protein that enhances the clustering of acetylcholine receptors&#x2014;was conserved in the mdECM (<xref ref-type="bibr" rid="B14">Choi et&#x20;al., 2016</xref>). In addition, dECM can be chemically processed or blended with other polymers before electrospinning or extrusion printing to fabricate a 3D scaffold integrated with tissue-specific biochemical cues and versatile structural cues (<xref ref-type="bibr" rid="B6">Baiguera et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B53">Kim et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B46">Kim et&#x20;al., 2021</xref>). <xref ref-type="bibr" rid="B6">Baiguera et&#x20;al. (2014)</xref> blended rat brain-derived dECM with gelatin prior to electrospinning and obtained a highly porous 3D scaffold that supported mesenchymal stem cell adhesion and growth. In another study, <xref ref-type="bibr" rid="B53">Kim et&#x20;al. (2020)</xref> developed a chemically modified dECM using a methacrylate process for the extrusion of cell-laden skeletal muscle constructs that offer structural stability.</p>
</sec>
<sec id="s3">
<title>3D Biofabrication Technologies in Skeletal Muscle Engineering</title>
<p>The recent biofabrication technologies that enabled recapitulation of the skeletal muscle physiology in terms of uniaxial cell orientation and bundle-like fiber organization are discussed in this section with a focus on the benefits of 3D bioprinting technology. In particular, 3D bioprinting technology facilitates the layer-by-layer deposition of cell-laden bioinks in desired dimension under the optimized ink composition and post-printing crosslinking steps, which endows the engineered constructs with more physiologically relevant dimensions. In addition, cells or larger units such as cell aggregates, cell sheets, and cell-laden modules can be placed and assembled using the 3D bioprinting technology in a native organ-resembling spatial arrangement to maximize the cell&#x2013;cell interaction.</p>
<sec id="s3-1">
<title>Mimicking Uniaxial Cell Alignment</title>
<p>In general, uniaxial cell alignment is a representative morphological feature of the skeletal muscles that can be induced by applying shear (<xref ref-type="bibr" rid="B68">Mozetic et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B51">Kim and Kim et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B50">Kim et&#x20;al., 2019</xref>) and tensile force (<xref ref-type="bibr" rid="B14">Choi et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B2">Agrawal et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B19">Cvetkovic et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B21">Das et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B55">Kong et&#x20;al., 2021</xref>). The shear flow inside a cylindrical nozzle induces shear-thinning of the polymer solution. The wall shear forces exerted on the shear-thinning polymer induce the alignment of inherent polymer molecules (<xref ref-type="bibr" rid="B17">Compton and Lewis, 2014</xref>; <xref ref-type="bibr" rid="B79">Schwab et&#x20;al., 2020</xref>). In particular, elongational forces are produced in the stretching region of the extruded polymer that can further accelerate the alignment and <xref ref-type="bibr" rid="B51">Kim et&#x20;al. (2019)</xref> studied the shear-induced cell-laden collagen alignment and demonstrated that a fibrillating buffer solution (KCl and <sc>l</sc>-glycine) incorporated in the bioink induces the formation of collagen fibril bundle, closely mimicking its native structure (<xref ref-type="bibr" rid="B51">Kim and Kim et&#x20;al., 2019</xref>). Based on their previous research, <xref ref-type="bibr" rid="B50">Kim et&#x20;al. (2019)</xref> included gold nanowire as a nanofiller that was stably aligned during the extrusion process and strongly aligned upon electric field stimulation (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). In addition, the orientation of the distribution of nanowires were manipulated under varying volume flow rates and nozzle speeds (<xref ref-type="bibr" rid="B50">Kim et&#x20;al., 2019</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>(A)</bold> Shear force-mediated cell alignment method. (a) Schematic of cell alignment during the extrusion printing process with gold nanowires aligned along the printing direction. (b) Electric field applied to promote the alignment of muscle cells through the alignment of gold nanowires. The optical images display the spatial distribution of gold nanowires under the electric field in directions perpendicular and parallel to the printing direction. (c) Distribution of orientation of gold nanowires under three conditions: no applied electric field (left), electric field applied in directions perpendicular (middle) and parallel (right) to the printing direction. Reprinted with permission from (<xref ref-type="bibr" rid="B50">Kim et&#x20;al., 2019</xref>). <bold>(B)</bold> 3D-printed anchor structure for applying tensile force. (a) 3D-printed muscle construct comprising geometric constraints and muscle cell-laden mdECM bioink in chain shape. (b) Live/dead staining of printed muscle constructs at Days 1, 4, 7, and 14 of culture, revealing high cell viability (&#x3e;90%) with minimal cell death. Construct compaction is accompanied by the longitudinal alignment of cells. Reprinted with permission from (<xref ref-type="bibr" rid="B14">Choi et&#x20;al., 2016</xref>).</p>
</caption>
<graphic xlink:href="fbioe-09-782333-g001.tif"/>
</fig>
<p>In order to apply tensile force, the muscle cell-laden hydrogels are confined around the two micropillars or posts. Upon tissue maturation and cell-mediated gel compaction, the hydrogel remain anchored to the posts and the cells align along the longest axis of the system. <xref ref-type="bibr" rid="B14">Choi et&#x20;al. (2016)</xref> induced uniaxial muscle cell alignment by depositing polycaprolactone (PCL) anchors as a geometric constraint at both ends of the muscle construct (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>). The PCL and cell-containing mdECM bioink were 3D printed using an integrated composite tissue/organ building system (<xref ref-type="bibr" rid="B14">Choi et&#x20;al., 2016</xref>). Alternatively, <xref ref-type="bibr" rid="B2">Agrawal et&#x20;al. (2017)</xref> fabricated a hydrogel pillar using a photopatterning method. After injecting the hydrogel precursor solution into an inlet of the microfluidic device, a prefabricated photomask was positioned on the bottom of the device, followed by exposure to ultraviolet (UV) radiation, which resulted in the formation of two circular pillars. Thereafter, the muscle cell-laden gelatin methacrylate solution was injected into the device for photopolymerization, which created patterns between the cells and around the pillars (<xref ref-type="bibr" rid="B2">Agrawal et&#x20;al., 2017</xref>).</p>
</sec>
<sec id="s3-2">
<title>Mimicking Muscle Bundle Structure</title>
<p>In native skeletal muscle, a single fascicle comprises multiple muscle fibers arranged in a bundled form. Several biofabrication techniques have attempted to mimic the muscle bundle-like structures for recapitulating the hierarchical arrangement ranging from a single muscle fiber to a fascicle. This physiological aspect can be achieved as follows: fabrication of bundle-shaped 3D scaffold (<xref ref-type="bibr" rid="B52">Kim et&#x20;al., 2018a</xref>; <xref ref-type="bibr" rid="B53">Kim et&#x20;al., 2020</xref>), 3D bioprinting cell-laden construct with built-in channels (<xref ref-type="bibr" rid="B65">Miller et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B43">Kang et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B54">Kolesky et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B49">Kim et&#x20;al., 2018b</xref>), and 3D embedded printing (<xref ref-type="bibr" rid="B8">Bertassoni et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B13">Choi et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B82">Skylar-Scott et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B31">Gao et&#x20;al., 2021</xref>).</p>
<p>A 3D scaffold comprising multiple polymeric struts or fibers adjacent to each other has been fabricated to mimic the bundle structure. <xref ref-type="bibr" rid="B52">Kim et&#x20;al. (2018a)</xref> demonstrated shear-induced poly (vinyl alcohol) (PVA) alignment during the printing of PVA/PCL mixture (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). Subsequent leaching of PVA yielded aligned micropatterns on the surface of the PCL scaffold, which was seeded with muscle cell-laden collagen solution (<xref ref-type="bibr" rid="B52">Kim et&#x20;al., 2018a</xref>). Alternatively, <xref ref-type="bibr" rid="B40">Jin et&#x20;al. (2021)</xref> fabricated the thermally drawn PCL fiber-based microchannel scaffolds (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>). After the scaffolds were soaked in the skeletal muscle dECM/muscle cell mixture and gelated at 37&#xb0;C, the nuclear elongation was observed along the orientation of fibers, indicating the cell-guiding effect of the aligned fiber structures. In addition, the highly porous scaffold surface obtained from the salt-leaching method allowed the absorption of the dECM pre-gel solution into the scaffolds, which was evident from the presence of collagen mesh-like structures on the inner and outer sides of the fiber (<xref ref-type="bibr" rid="B40">Jin et&#x20;al., 2021</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> Fabrication of PCL strut-based 3D scaffold. (a) Optical and scanning electron microscopy (SEM) images of micropatterned PCL scaffold. (b) Confocal images of cells at Day 14 immunostained for myosin heavy chain (green) and nuclei (blue), indicating the myogenic differentiation induced on the micropatterned PCL scaffold. Reprinted with permission from (<xref ref-type="bibr" rid="B52">Kim et&#x20;al., 2018a</xref>). <bold>(B)</bold> Fabrication of thermally drawn PCL-fiber based 3D scaffold. (a) SEM images of PCL fiber-based scaffold after dECM absorption on scaffold surface. Reprinted with permission from (<xref ref-type="bibr" rid="B40">Jin et&#x20;al., 2021</xref>). <bold>(C)</bold> 3D bioprinted cell-laden construct with built-in channels. (a) Schematic of integrated tissue-organ printing system. (b) 3D bioprinted multilayered muscle construct at scale: 15 &#xd7; 15 &#xd7; 15&#xa0;cm. Microchannels are formed inside the construct after removal of gelatin patterns. Reprinted with permission from (<xref ref-type="bibr" rid="B49">Kim et&#x20;al., 2018b</xref>).</p>
</caption>
<graphic xlink:href="fbioe-09-782333-g002.tif"/>
</fig>
<p>Microchannel-guided formation of aligned units has been utilized in a broad range of target tissues, including bone, nervous tissues, and vasculatures (<xref ref-type="bibr" rid="B20">Daly et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B36">Huang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B58">Lee et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B37">Hwangbo et&#x20;al., 2021</xref>). Sacrificial hydrogels&#x2014;deposited as a temporary structure for structural support or generation of certain structures&#x2014;are often removed by variations in temperature once the crosslinking of the engineered construct is complete; therefore, they have been widely adopted in 3D bioprinting for establishing built-in channels. In addition, thermoresponsive sacrificial polymers (i.e.,&#x20;gelatin and Pluronic F-127 (PF-127)) are printed as a temporary structure that dissolve in response to temperature variations after the bulk hydrogel has been crosslinked. <xref ref-type="bibr" rid="B43">Kang et&#x20;al. (2016)</xref> printed supporting PCL pillars and sacrificial hydrogel patterns between cell-laden hydrogel patterns to yield a muscle bundle-like structure. Moreover, stretching and aligning muscle cells were observed inside these bundle structures 3&#xa0;days after printing structure (<xref ref-type="bibr" rid="B43">Kang et&#x20;al., 2016</xref>). Subsequently, <xref ref-type="bibr" rid="B49">Kim et&#x20;al. (2018b)</xref> developed a larger construct (mm<sup>3</sup>&#x2013;cm<sup>3</sup>) with multilayered muscle bundles to utilize cells from human biopsies and assess if the construct was applicable for severe muscle defect replacement (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>; <xref ref-type="bibr" rid="B49">Kim et&#x20;al., 2018b</xref>).</p>
<p>Furthermore, 3D embedded printing utilizes a recently developed printing method named freeform reversible embedding of suspended hydrogel (FRESH). The major limitation of soft biomaterials such as ECM hydrogels is attributed to their poor shape-retention during the printing process that renders the desired resolution and 3D geometries unachievable (<xref ref-type="bibr" rid="B35">Hinton et&#x20;al., 2015</xref>). The thermoreversible support bath prevents the collapse of the printed hydrogels and is subsequently melted away after the printing process. Moreover, complex structures such as branched tubular networks and trileaflet heart valves have been fabricated using the FRESH method (<xref ref-type="bibr" rid="B9">Bhattacharjee et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B57">Lee et&#x20;al., 2019</xref>). Based on this method, <xref ref-type="bibr" rid="B13">Choi et&#x20;al. (2019)</xref> directly printed a bundle-like structure in a granule-based support bath. Initially, they prepared the support bath by blending an 8% (w/v) gelatin solution to generate gelatin granules. Thereafter, mdECM struts were directly printed into the support bath with horizontal and vertical distances of 200&#xa0;&#xb5;m from each other. Subsequently, PVA was added into the gelatin granule to induce rapid polymerization of mdECM bioink during its extrusion (<xref ref-type="bibr" rid="B13">Choi et&#x20;al., 2019</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>Maturation of 3D Tissue-Engineered Muscle</title>
<p>The development of 3D-engineered muscles results in physiologically mimetic tissues that can reflect the phenotypes that remain undiscovered or neglected in conventional systems. In this section, we discuss the recent biofabrication technologies for vascularization and innervation. Skeletal muscle vasculature participates in specific interactions with myofibers, which aid in muscle maturation and homeostasis. In particular, vascular endothelial growth factor (VEGF) stimulates the Akt pathway of muscle cells and induces myofiber hypertrophy in an autocrine manner (<xref ref-type="bibr" rid="B88">Yin et&#x20;al., 2013</xref>). Long-term denervation or depletion of motor neuron innervation prohibits satellite cells from entering the mitotic cell cycle and leads to progressive myofiber atrophy (<xref ref-type="bibr" rid="B56">Kuschel et&#x20;al., 1999</xref>). In addition, we review the studies that utilized electrical and mechanical stimuli for the maturation of 3D-engineered muscles.</p>
<sec id="s4-1">
<title>Vascularization</title>
<p>To date, several vascularization strategies have been developed to recapitulate the native vascular function (i.e.,&#x20;nutrient and oxygen supply to the highly oxygen-consuming organ) in the 3D-engineered muscle. The coaxial printing method and direct ink-writing method have been studied for the vascularization of engineered muscle as well as engineered tissues of other&#x20;types.</p>
<p>Among the conventional vascularization methods, the hydrogel mold-casting method can generate hollow channel structures that are subsequently seeded with endothelial cells (ECs), forming endothelialized lumen structures (<xref ref-type="bibr" rid="B7">Bersini et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B73">Osaki et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B77">Redd et&#x20;al., 2019</xref>). <xref ref-type="bibr" rid="B73">Osaki et&#x20;al. (2018)</xref> observed emergent angiogenic sprouting from the surface of the endothelialized channels towards the muscle bundle between two channels, which mimicked myokine-regulated muscle angiogenesis. However, this method requires sequential stereolithography-based steps for obtaining the micropatterned mold. The multiple channel structures should be individually obtained to allow active diffusion of nutrients, thereby adding complexity to the mold-preparation&#x20;step.</p>
<p>In general, 3D printing enables the iterative one-step fabrication of composite structures. For instance, the coaxial printing method enables direct fabrication of two- (<xref ref-type="bibr" rid="B89">Zhang et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B30">Gao et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B13">Choi et&#x20;al., 2019</xref>) or three- (<xref ref-type="bibr" rid="B29">Gao et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B31">Gao et&#x20;al., 2021</xref>) layered 3D conduits of varying geometries and dimensions (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). <xref ref-type="bibr" rid="B89">Zhang et&#x20;al. (2016)</xref> bioprinted a 3D microfibrous scaffold structure using a composite bioink comprising alginate (GelMA) and photoinitiator. The alginate in the core part of the nozzle was exposed to a chemical crosslinking agent (Ca<sup>2&#x2b;</sup>) provided from the shell part of the nozzle during the printing process. The printed scaffold manifested mechanical stability after the UV crosslinking of GelMA. Ultimately, the cardiomyocytes were seeded onto the stiffened microfibrous scaffold after the bioprinted ECs self-assembled into a layer of confluent endothelium, thereby resembling the structure of native myocardium (<xref ref-type="bibr" rid="B89">Zhang et&#x20;al., 2016</xref>). In another research, <xref ref-type="bibr" rid="B13">Choi et&#x20;al. (2019)</xref> fabricated a compartmentalized core&#x2013;shell structure in which a layer of ECs surrounded the muscle fiber-like struts, thereby closely mimicking the hierarchical architecture of vascularized muscle. Within a coaxial nozzle, the syringe containing the muscle cell-laden mdECM bioink and the syringe containing the EC-laden vascular dECM bioink were attached to the core and shell parts, respectively. In comparison to the muscle-only construct, the higher twitch and tetanic peak forces of the vascularized muscle confirmed its enhanced maturity (<xref ref-type="bibr" rid="B13">Choi et&#x20;al., 2019</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>
<bold>(A)</bold> Coaxial printing method. (a) Formulation of vascular tissue-derived bioinks for promoting vascular maturation. (b) Schematic of triple-coaxial cell printing method yielding compartmentalized vascular structure. (c) Confocal image of printed vascular structure with combined expression of endothelial and muscular markers. Reprinted with permission from (<xref ref-type="bibr" rid="B29">Gao et&#x20;al., 2019</xref>). <bold>(B)</bold> Direct ink-writing method. (a) Sequence of branched and hierarchical vascular network fabricated with direct ink-writing method. (b) Perfusion of ECs into evacuated channel (white-dashed lines). (c) Expression of VE-cadherin after 20&#xa0;h of perfusion displays formation of endothelium monolayer. Reprinted with permission from (<xref ref-type="bibr" rid="B82">Skylar-Scott et&#x20;al., 2019</xref>).</p>
</caption>
<graphic xlink:href="fbioe-09-782333-g003.tif"/>
</fig>
<p>The direct ink writing method proposed by <xref ref-type="bibr" rid="B82">Skylar-Scott et&#x20;al. (2019)</xref> enables the fabrication of complex vasculature in a cell-filled support bath via 3D embedded printing (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). This method is novel owing to the high cellular density of the support bath (up to 10<sup>8</sup>&#xa0;cells/ml) (i.e.,&#x20;living tissue matrix) which is the prerequisite for physiologically relevant tissue models. The living tissue matrix exhibited a self-healing, viscoplastic behavior that allowed the printing of sacrificial ink in the desired network structure without crevasses formation on the printing path. Subsequently, the temperature-mediated melting of sacrificial gelatin ink and the simultaneous stiffening of the matrix yielded hollow vasculature networks, followed by the perfusion of EC suspension (<xref ref-type="bibr" rid="B82">Skylar-Scott et&#x20;al., 2019</xref>). Based on a similar approach, <xref ref-type="bibr" rid="B70">Neufeld et&#x20;al. (2021)</xref> fabricated a 3D glioblastoma model with a perfusable vasculature. Initially, the PF-127-based vascular bioink was deposited on the surface of cancer cell-laden fibrin bioink, followed by casting another layer of fibrin bioink onto the vasculature. Once the fibrin bioink achieved the desired physiological stiffness, the PF-127 was washed out with cold PBS, and a mixture of ECs and pericytes were injected into the vascular channels (<xref ref-type="bibr" rid="B70">Neufeld et&#x20;al., 2021</xref>). Overall, the direct ink-writing method allows freeform fabrication of tissue-specific vascular structures. However, the mechanical properties of the support bath inks and vascular inks should be carefully manipulated in combination to achieve the desired geometry of vasculatures.</p>
</sec>
<sec id="s4-2">
<title>Innervation</title>
<p>Motor neuron innervates the skeletal muscle via neuron&#x2013;myofiber contacts or neuromuscular junctions (NMJs), which mediate the conversion of neuronal signal into muscle contraction. Functional NMJs have been engineered by multiple biofabrication methods including 3D co-culture (<xref ref-type="bibr" rid="B66">Morimoto et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B1">Bakooshli et&#x20;al., 2019</xref>) of neuron and myofibers, and 3D bioprinting of structures with a spatial organization that induces spontaneous neurite formation (<xref ref-type="bibr" rid="B19">Cvetkovic et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B48">Kim et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B55">Kong et&#x20;al., 2021</xref>).</p>
<p>In particular, the neurons can self-organize to form NMJs in the 3D co-culture of motor neurons (MNs) and muscle cells. Multiple biofabrication skills, including the usage of patterned stamps and molds, facilitate the integration of MN spheroids with differentiated myofibers. <xref ref-type="bibr" rid="B66">Morimoto et&#x20;al. (2013)</xref> used polydimethylsiloxane (PDMS) stamps for patterning Matrigel to form aligned muscle bundle, and subsequently, added mouse neural stem cell-derived spheroids (mNSCs) onto the muscle bundle. The mNSCs were successfully differentiated into motor neurons, and acetylcholine receptors were formed at the muscle bundle-spheroid contacts. Moreover, the muscle bundle contracted unidirectionally in response to glutamic acid activation of neurons, indicating the formation of functional NMJs (<xref ref-type="bibr" rid="B66">Morimoto et&#x20;al., 2013</xref>). Based on a similar approach, <xref ref-type="bibr" rid="B1">Bakooshli et&#x20;al. (2019)</xref> prepared a dumbbell-shaped PDMS mold that was seeded with a mixture of human pluripotent cell-derived MN spheroids and human muscle progenitor cells suspended in fibrin-based hydrogel (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>; <xref ref-type="bibr" rid="B1">Bakooshli et&#x20;al., 2019</xref>). The expression of NMJ-localized protein, such as synaptic MuSK protein, confirmed the recapitulation of early NMJ synaptogenesis in this&#x20;model.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>
<bold>(A)</bold> 3D muscle&#x2013;motor neuron co-culture. (a) phase contrast image portraying differentiated myofiber co-cultured with motor neuron spheroid for 2&#xa0;weeks. (b) Confocal image displaying co-localization of neurite terminals (red) and acetylcholine clusters (magenta/white) on a striated myofiber (green). SAA: sarcomeric &#x3b1;-actinin, SMI32: anti-200 kD neurofilament heavy antibody, BTX: &#x3b1;-bungarotoxin. Reprinted with permission from (<xref ref-type="bibr" rid="B1">Bakooshli et&#x20;al., 2019</xref>). <bold>(B)</bold> 3D bioprinted innervated muscle construct. (a) 3D CAD modeling of bioprinted construct. Hollow microchannels formed after removing sacrificial patterns. (b) Confocal image of acetylcholine receptors (green) prepatterned on myofibers (red). (c) Confocal image of neurites (red) contacting acetylcholine receptor clusters (green). &#x3b2;IIIT: beta-III tubulin. Reprinted with permission from (<xref ref-type="bibr" rid="B48">Kim et&#x20;al., 2020</xref>). <bold>(C)</bold> Modular muscle&#x2013;motor neuron co-culture system. (a) Schematic of fabrication of multilayered tissue ring. The cross-sectional tissue area decreased over time as cell&#x2013;gel solution compacted around the mold. (b) Confocal image indicating differentiated myofibers (red) and motor neuron EBs (green). Hb9: post-mitotic MN-specific Hb9 promoter. MF20: anti-myosin heavy-chain antibody. Reprinted with permission from (<xref ref-type="bibr" rid="B19">Cvetkovic et&#x20;al., 2017</xref>).</p>
</caption>
<graphic xlink:href="fbioe-09-782333-g004.tif"/>
</fig>
<p>In addition, 3D bioprinting technology facilitates the precise positioning of multiple cell types in a desired organization and array. <xref ref-type="bibr" rid="B48">Kim et&#x20;al. (2020a)</xref> generated a functional NMJ inside a 3D-printed multilayered bundle-shaped construct containing a hollow microchannel structure (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>). Fibrinogen/gelatin/hyaluronic acid/glycerol bioink containing human muscle progenitor cells and human neural stem cells (hNSCs), acellular sacrificial bioink, and a supporting PCL pillar were deposited using multidispensing modules. Consequently, &#x3b2;IIIT<sup>&#x2b;</sup> neurites contacting the acetylcholine receptor clusters were formed on the myofibers, which confirm the formation of NMJs (<xref ref-type="bibr" rid="B48">Kim et&#x20;al., 2020</xref>). In an alternative approach, <xref ref-type="bibr" rid="B19">Cvetkovic et&#x20;al. (2017)</xref> used a stereolithography-based 3D-printing technique to fabricate a modular co-culture system (<xref ref-type="fig" rid="F4">Figure&#x20;4C</xref>). A 3D tissue ring, previously formed by integrating two layers comprising differentiated myofibers and motor neuron embryoid bodies (EBs) in a 3D-printed ring mold, was transferred to the hydrogel skeleton to mimic the physiological muscle&#x2013;tendon&#x2013;bone arrangement. This co-culture arrangement exhibited the extension of the neurite toward the differentiated muscle and the formation of the acetylcholine receptor cluster (<xref ref-type="bibr" rid="B19">Cvetkovic et&#x20;al., 2017</xref>).</p>
</sec>
<sec id="s4-3">
<title>Contractility</title>
<p>Contractility is one of the most widely accepted muscle functional readouts for distinguishing between normal and diseased muscle phenotypes (<xref ref-type="bibr" rid="B81">Sharples et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B42">Juhas et&#x20;al., 2018</xref>). In context, the early detachment of spontaneously contracting myofibers allowed only partial contractility analysis in 2D cultures, which were confined to the variations in related gene expressions (<xref ref-type="bibr" rid="B71">Nikoli&#x107; et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B83">Tarum et&#x20;al., 2017</xref>). Various external stimuli have been applied to improve the contractility of the 3D-engineered muscle. These stimuli aim to mimic the native stimuli the developing skeletal muscle receives (<xref ref-type="bibr" rid="B87">Westerga and Gramsbergen, 1994</xref>; <xref ref-type="bibr" rid="B23">Eken et&#x20;al., 2008</xref>), which induce muscle hypertrophy. In general, electrical stimulation and mechanical loading are frequently utilized in combination.</p>
<p>First, electrical stimulation is applied as a surrogate of neural input that are delivered to individual myofibers to induce muscular contraction. In addition, the regenerating muscles in the self-repair process require electrical signals from motor neurons, implying that the electrical stimulation can enhance the function of the engineered muscle (<xref ref-type="bibr" rid="B47">Kim et&#x20;al., 2019</xref>). Upon applying the electrical stimulation, the pulse energy and width should be optimized to minimize the tissue damage (<xref ref-type="bibr" rid="B44">Khodabukus and Baar, 2012</xref>). <xref ref-type="bibr" rid="B33">Grosberg et&#x20;al. (2011)</xref> applied an electrical field stimulation for cantilever-type thin muscular films and measured the transmembrane potential of cardiomyocytes. This revealed an action potential morphology, indicating the contractility achieved in the tissue (<xref ref-type="bibr" rid="B33">Grosberg et&#x20;al., 2011</xref>). Additionally, <xref ref-type="bibr" rid="B45">Khodabukus et&#x20;al. (2019)</xref> demonstrated that a 3D-engineered muscle electrically stimulated with 1 and 10&#xa0;Hz of frequency for 1&#xa0;week resulted in an increased contractile force (nonstimulated: 9.1&#x20;&#xb1; 0.38&#xa0;mN&#xa0;mm<sup>&#x2212;2</sup>, 1&#xa0;Hz: 19.3&#x20;&#xb1;&#x20;0.63&#xa0;mN&#xa0;mm<sup>&#x2212;2</sup>, 10&#xa0;Hz: 18.9&#x20;&#xb1; 0.69&#xa0;mN&#xa0;mm<sup>&#x2212;2</sup>). More importantly, the stimulation of 1&#xa0;Hz enabled the highest specific force generation among the outputs of engineered human muscle reported to date (<xref ref-type="bibr" rid="B45">Khodabukus et&#x20;al., 2019</xref>).</p>
<p>On the other hand, mechanical loading mimics the consistent passive stretch exerted upon the embryonic muscle. <xref ref-type="bibr" rid="B47">Kim et&#x20;al. (2019)</xref> reported that combined electrical and mechanical stimulation induced the remodelling of ECM network structures in engineered muscle tissue, such that the force transmission was facilitated without impeding muscle contraction. In particular, 20&#xa0;min of alternating electrical and mechanical stimulations resulted in 31% higher contractile force (<xref ref-type="bibr" rid="B47">Kim et&#x20;al., 2019</xref>). Moreover, <xref ref-type="bibr" rid="B3">Aguilar-Agon et&#x20;al. (2019)</xref> studied the influences of mechanical loading on anabolic shift based on the results of <italic>in vivo</italic> resistance exercise regimens. Insulin-like growth factor-1, which is associated in skeletal muscle growth, was upregulated 21&#xa0;h after the cessation of mechanical load (15% elongation of engineered construct); after 45&#xa0;h from cessation, the atrophic gene MAFbx underwent significant downregulation. In addition, maximal isometric force exhibited an increase of 140% (21&#xa0;h) and 265% (45&#xa0;h) as compared to nonloaded constructs (<xref ref-type="bibr" rid="B3">Aguilar-Agon et&#x20;al., 2019</xref>). Collectively, the electrical stimulation and mechanical loading could result in significant muscle hypertrophy and increase in force generation, which can potentially enable the maturation of engineered muscle to a similar extent as that in human adult muscle.</p>
</sec>
</sec>
<sec id="s5">
<title>Recapitulation of Skeletal Muscle Tissue-Related Diseases</title>
<p>The representation of a more human-like pathology for preclinical studies relies on the maturity and complexity of the model. In context, several muscle-disease phenotypes have been achieved in 3D-engineered skeletal muscles, which were not earlier displayed in 2D cultures or animal models. The recent studies conducted using a 3D-engineered muscle model that recapitulated the major disease phenotypes of severe muscular dystrophies (MDs) and inflammatory muscle diseases are discussed and reviewed herein.</p>
<sec id="s5-1">
<title>Muscular Dystrophies and Muscle Weakness</title>
<p>Muscular dystrophies arise from mutations in genes encoding various proteins such as muscle ECM, cytoplasmic and plasma membrane proteins that result in progressive muscle weakness or wasting (<xref ref-type="bibr" rid="B84">Tedesco and Cossu, 2012</xref>). The most common and severe type of dystrophy, DMD, is an X-linked recessive disorder that occurs almost exclusively in males. The underlying mechanism of DMD is attributed to the mutation in the gene encoding dystrophin, a membrane-bound cytoskeletal protein that links the intracellular actin cytoskeleton to extracellular matrix. Therefore, the absence of dystrophin destabilizes the membranes and causes consistent muscle fiber damage during contraction, which results in consistent fiber degeneration (<xref ref-type="bibr" rid="B72">Nowak and Davies, 2004</xref>; <xref ref-type="bibr" rid="B5">Allen and Whitehead, 2010</xref>).</p>
<p>Thus, patient-derived cells are cultured under uniaxial tension or micropatterned substrates to form a 3D myofiber for modeling DMD. During and after the culture, the cells are screened for degenerative morphologies such as less sarcomeric &#x3b1;-actinin organization and decreased contractile force. <xref ref-type="bibr" rid="B69">Nesmith et&#x20;al. (2016)</xref> fabricated a thin, contractile muscular film composed of DMD patient-derived cells in a cantilevered design by printing an array of thin bands using a microcontact printing method (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>). Under electrical stimulation with increasing frequencies ranging from 1 to 4&#xa0;Hz, the dynamic stress on the healthy tissues on day 6 was at least one order of magnitude higher in comparison to the diseased tissues, as evaluated based on the variations in the radius of film curvature. The results implied that the impaired force transmission caused by the absence of dystrophin was recapitulated in this system (<xref ref-type="bibr" rid="B69">Nesmith et&#x20;al., 2016</xref>). Subsequently, <xref ref-type="bibr" rid="B45">Khodabukus et&#x20;al. (2019)</xref> used fibrin-based 3D &#x201c;myobundles&#x201d; confined to rectangular Teflon frames to demonstrate the correct membrane-bound localization of dystrophin. Moreover, the electrical stimulation increased the dystrophin, myosin heavy chain, and sarcomeric &#x3b1;-actinin content (<xref ref-type="bibr" rid="B45">Khodabukus et&#x20;al., 2019</xref>). Overall, the 3D-engineered muscle models can represent more adult-like phenotypes as compared to the developmentally less matured cytoplasmic localization of dystrophin in conventional 2D culture (<xref ref-type="bibr" rid="B80">Serena et&#x20;al., 2016</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>
<bold>(A)</bold> Engineered human DMD model in cantilevered design. (a) Schematic of tissues undergoing baseline and peak stress. (b) Baseline, peak, and dynamic stress in healthy tissues at day 3 and day 6, and in DMD tissues at day 6. Reprinted with permission from (<xref ref-type="bibr" rid="B69">Nesmith et&#x20;al., 2016</xref>). <bold>(B)</bold> Patient-derived iPSC-based engineered LMNA model. (a) Whole-mount confocal images of myotubes (gray) and nuclear lamina (green for LAMIN A/C and red for emerin) on iPSC-based engineered muscles derived from healthy and two LMNA mutants. (b) 3D nuclear reconstructions of patient-derived iPSCs differentiated in 3D-engineered muscles highlight more prominent nuclear deformities and elongation as compared to monolayer cultures. Reprinted with permission from (<xref ref-type="bibr" rid="B61">Maffioletti et&#x20;al., 2018</xref>). <bold>(C)</bold> Engineered human cardiac muscle for modeling exercise-mediated attenuation of IFN-&#x3b3;-induced muscle wasting. (a) Cross-sections of engineered muscle immunostained for dystrophin indicates attenuated muscle atrophy under exercise&#x2013;mimetic electrical stimulation. (b) Longitudinal sections of engineered muscle immunostained for F-actin (green) and sarcomeric &#x3b1;-actinin (red). Electrical stimulation prevented IFN-&#x3b3;-induced decrease of sarcomere organization. Reprinted with permission from (<xref ref-type="bibr" rid="B12">Chen et&#x20;al., 2021</xref>).</p>
</caption>
<graphic xlink:href="fbioe-09-782333-g005.tif"/>
</fig>
<p>
<xref ref-type="bibr" rid="B61">Maffioletti et&#x20;al. (2018)</xref> applied a tensile force to fibrin-based 3D engineered tissue and generated a multilineage patient-specific model using a patient-derived iPSC of laminopathy (LMNA), which is one of the MD types (<xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>). LMNA results from the mutation of the LAMIN A/C gene encoding a protein that composes the nuclear lamina. Under uniaxial tension, hiPSCs were successfully differentiated into myofiber-resembling structures. Notably, the genotype&#x2013;phenotype correlation was achieved as hiPSCs displayed significant nuclear abnormalities such as nuclear elongation, which was absent in normal muscles and other dystrophic hiPSC lines (<xref ref-type="bibr" rid="B61">Maffioletti et&#x20;al., 2018</xref>). Moreover, <xref ref-type="bibr" rid="B7">Bersini et&#x20;al. (2018)</xref> demonstrated a multicellular DMD model composed of cells from human biopsy to mimic the aberrant fibrosis. They fabricated a spatially organized mesoscale system where differentiated myofibers were surrounded by 3D microvascular network and a fibroblast layer. In particular, collagen and fibronectin secretion levels were significantly higher in patient-derived fibroblasts as compared to normal and TGF-&#x3b2;1 treated fibroblasts. This trend was not displayed in 2D triculture system, indicating that the 3D mesoscale system supported more physiologically relevant fibrosis progression such as muscle-specific fibroblast recruitment. Furthermore, the &#x3b1;-smooth muscle actin, which is expressed in the fibroblasts residing in the dystrophic muscle, was expressed in high levels in the DMD fibroblasts, thereby indicating an accurate representation of the DMD-affected tissue microenvironment (<xref ref-type="bibr" rid="B7">Bersini et&#x20;al., 2018</xref>).</p>
</sec>
<sec id="s5-2">
<title>Inflammatory Muscle Disease and Skeletal Muscle Self-Repair</title>
<p>Skeletal muscle self-repair in response to mild injuries is modulated by the interaction between the muscle-resident satellite cells and the immune system via the process of satellite cell activation, proliferation, and differentiation. However, excessive and unregulated inflammatory responses are associated with muscle loss and weakness, which has been reported in several types of diseases including sarcopenia, cachexia, chronic obstructive pulmonary disease and rheumatoid arthritis. In particular, several clinical studies have reported that elevated IFN-&#x3b3; levels in autoimmune diseases and chronic inflammation contribute toward muscle wasting.</p>
<p>Based on a 3D fibrin-based engineered cardiac muscle tissue composed of human primary cells, <xref ref-type="bibr" rid="B12">Chen et&#x20;al. (2021)</xref> assessed the influence of exercise on IFN-&#x3b3;-induced muscle wasting (<xref ref-type="fig" rid="F5">Figure&#x20;5C</xref>). In this model, muscle atrophy was characterized by weaker and slower muscle contraction and reduced calcium-handling protein expression. Notably, the exercise-mimetic electrical stimulation with IFN-&#x3b3; treatment rescued the sarcomeric protein organization and elongated the myotube, thereby implying an attenuated muscle atrophy condition. In particular, inhibited expression of IFN-&#x3b3;-induced JAK (Janus kinase)/STAT (signal transducer and activator of transcription) pathway downstream proteins suggested the previously unknown, exercise-mediated cell autonomous anti-inflammatory response that occurs in the muscle tissue, besides the paracrine signalling which has been traditionally suggested as the fundamental mechanism. Furthermore, prevention of muscle atrophy after treatment of FDA-approved small-molecule inhibitors of JAK/STAT pathway confirmed the utility of this platform for preclinical drug screening (<xref ref-type="bibr" rid="B12">Chen et&#x20;al., 2021</xref>).</p>
<p>
<xref ref-type="bibr" rid="B42">Juhas et&#x20;al. (2018)</xref> established a 3D co-culture system based on previously referred 3D engineered muscle to assess the role of macrophages in skeletal muscle regeneration process. An inhibited endogenous self-repair process was successfully mimicked as progressive myofiber degeneration was induced after cardiotoxic injury, which resembled a severe muscle injury. Then a robust regenerative response was induced upon incorporating bone-marrow derived macrophages with lower levels of activated caspase 3, which indicated that the anti-apoptotic paracrine signalling between the muscle and macrophages were mimicked in this model. Furthermore, the implantation of macrophage-incorporated engineered muscles in a mouse dorsal window-chamber model resulted in robust blood vessel ingrowth and functional muscle regeneration. As such, the <italic>in&#x20;vitro</italic> incorporation of macrophages can be considered as an effective approach for preconditioning an implantable construct in a pro-regenerative milieu before implantation (<xref ref-type="bibr" rid="B42">Juhas et&#x20;al., 2018</xref>).</p>
</sec>
</sec>
<sec id="s6">
<title>Future Applications</title>
<p>To date, the incorporation of patient-derived cells and induction of chemical injuries in 3D-engineered muscle models have successfully modeled multiple types of muscle diseases. Although several muscle diseases exhibit combined features of muscle and connective tissue pathology (e.g., limb-girdle muscular dystrophy) (<xref ref-type="bibr" rid="B18">Csapo et&#x20;al., 2020</xref>), only certain models have utilized the aspect of the diseased ECM. Aberrant fibrosis accounts for one of the most prominent features of DMD (<xref ref-type="bibr" rid="B7">Bersini et&#x20;al., 2018</xref>), as it causes the accumulation of collagen I and fibronectin. In particular, the combination of mechanical stimuli and diseased ECM could accurately model the progression of multiple type of unveiled muscular dystrophies. Moreover, 3D muscle-like architecture in engineered muscles might aid in the accurate recapitulation of the cell&#x2013;matrix interaction.</p>
<p>In addition, engineering a native satellite cell niche-mimicking microenvironment is an emerging topic. In an attempt to preserve satellite cell quiescence <italic>in&#x20;vitro</italic>, <xref ref-type="bibr" rid="B75">Quarta et&#x20;al. (2016)</xref> fabricated a 3D-engineered muscle composed of muscle satellite cells using a micropost platform. They screened for the micropost stiffness that was known to affect the stem cell behaviour. Moreover, they defined the factors that could assist satellite cell quiescence <italic>in&#x20;vitro</italic> and applied it in the culture of the engineered muscle (<xref ref-type="bibr" rid="B75">Quarta et&#x20;al., 2016</xref>). Alternatively, <xref ref-type="bibr" rid="B59">Lee et&#x20;al. (2020)</xref> utilized a 3D microfluidic platform to establish vascular architecture of the satellite cell niche <italic>in&#x20;vitro</italic>, where the intercirculation of niche factors between young and old satellite cells were demonstrated (<xref ref-type="bibr" rid="B59">Lee et&#x20;al., 2020</xref>). These models are potentially useful for modelling the satellite cell activation, quiescence, self-renewal and differentiation (<xref ref-type="bibr" rid="B39">Ishii et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B18">Csapo et&#x20;al., 2020</xref>) which all aid in skeletal muscle self-repair mechanism (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Biofabrication of skeletal muscle disease models. Multiple biomaterials and biofabrication techniques can be utilized to develop 3D-engineered muscle with native tissue-like stiffness and topography (top). Functional maturation of 3D-engineered tissue is achieved by vascularization, innervation and electrical/mechanical stimuli (middle). With the incorporation of patient-derived hiPSCs, addressed biofabrication techniques can be applied in recapitulation of muscle disease-related phenotypes <italic>in&#x20;vitro.</italic> In addition, they could be applied in engineering of native satellite cell niche for the study of muscle self-repair mechanism, and for the preservation of satellite cell quiescence <italic>in&#x20;vitro</italic>, which enhances the therapeutic efficacy of cells (bottom).</p>
</caption>
<graphic xlink:href="fbioe-09-782333-g006.tif"/>
</fig>
<p>The preservation of satellite cell quiescence impacts the therapeutic efficacy of the cells as well. <xref ref-type="bibr" rid="B39">Ishii et&#x20;al. (2018)</xref> identified a laminin-type component of basement membrane that encapsulates satellite cells. Thereafter, they prepared a recombinant protein that partially contained the C-terminal of the original basement membrane component, which was mixed with Matrigel. Under the <italic>in&#x20;vitro</italic> culture of using the substrate, the satellite cell quiescence was preserved, and the enhanced muscle regeneration capacity was confirmed <italic>in vivo</italic> (<xref ref-type="bibr" rid="B39">Ishii et&#x20;al., 2018</xref>). Overall, these approaches would endow isolated primary cells with enhanced engraftment potential and muscle regeneration capacities, which could facilitate the improvement of current regenerative therapies for volumetric muscle&#x20;loss.</p>
<p>Endogenous muscle self-repair is supported by interactions between muscle satellite cells and multiple types of muscle-resident cells, including macrophages, CD3<sup>&#x2b;</sup> T&#x20;cells, endothelial cells, and fibro-adipogenic progenitors that collectively form a complex inflammatory milieu (<xref ref-type="bibr" rid="B27">Fu et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B76">Quarta et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B41">Judson et&#x20;al., 2020</xref>). However, current <italic>in&#x20;vitro</italic> models of muscle self-repair partially recapitulate the microenvironment of the regenerating muscle, as satellite cells are co-cultured with either macrophages or endothelial cells (<xref ref-type="bibr" rid="B42">Juhas et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B59">Lee et&#x20;al., 2020</xref>). Therefore, the incorporation of multiple cell types is required for an in-depth understanding of the mechanism of satellite cell quiescence in regenerating muscles. Moreover, the sorting and expansion of the desired cell population among a larger pool of cells remain challenges for obtaining a sufficient number of cells and in applying these models in preclinical settings.</p>
</sec>
</body>
<back>
<sec id="s7">
<title>Author Contributions</title>
<p>SC and JJ contributed with the draft design and conception. SC wrote the original draft and organized the figures, and JJ revised the draft and supervised the work. All authors agree on the final submission of the manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2020M3H4A1A02084827). This work was also supported by Korean Fund for Regenerative Medicine funded by Ministry of Science and ICT, and Ministry of Health and Welfare (NRF-2021M3E5E5096524, Republic of Korea).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afshar Bakooshli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lippmann</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Mulcahy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>C. T.</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A 3d Culture Model of Innervated Human Skeletal Muscle Enables Studies of the Adult Neuromuscular junction</article-title>. <source>eLife</source> <volume>8</volume>, <fpage>1</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.7554/eLife.44530</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agrawal</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Aung</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Varghese</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Skeletal Muscle-On-A-Chip: An <italic>In Vitro</italic> Model to Evaluate Tissue Formation and Injury</article-title>. <source>Lab. Chip</source> <volume>17</volume>, <fpage>3447</fpage>&#x2013;<lpage>3461</lpage>. <pub-id pub-id-type="doi">10.1039/c7lc00512a</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguilar-Agon</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>Capel</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>N. R. W.</given-names>
</name>
<name>
<surname>Player</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Mechanical Loading Stimulates Hypertrophy in Tissue-Engineered Skeletal Muscle: Molecular and Phenotypic Responses</article-title>. <source>J.&#x20;Cel. Physiol</source> <volume>234</volume>, <fpage>23547</fpage>&#x2013;<lpage>23558</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.28923</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alfano</surname>
<given-names>L. N.</given-names>
</name>
<name>
<surname>Charleston</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Cripe</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Donoghue</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dracker</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Long-term Treatment with Eteplirsen in Nonambulatory Patients with Duchenne Muscular Dystrophy</article-title>. <source>Medicine</source> <volume>98</volume>, <fpage>e15858</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000015858</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Whitehead</surname>
<given-names>N. P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Duchenne Muscular Dystrophy-Wwhat Causes the Increased Membrane Permeability in Skeletal Muscle</article-title>. <source>Int. J.&#x20;Biochem. Cel Biol.</source> <volume>43</volume>, <fpage>290</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2010.11.005</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baiguera</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Del Gaudio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lucatelli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kuevda</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Boieri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mazzanti</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Electrospun Gelatin Scaffolds Incorporating Rat Decellularized Brain Extracellular Matrix for Neural Tissue Engineering</article-title>. <source>Biomaterials</source> <volume>35</volume>, <fpage>1205</fpage>&#x2013;<lpage>1214</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.10.060</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bersini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gilardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ugolini</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Sansoni</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Tal&#xf2;</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Perego</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Engineering an Environment for the Study of Fibrosis: A 3D Human Muscle Model with Endothelium Specificity and Endomysium</article-title>. <source>Cel Rep.</source> <volume>25</volume>, <fpage>3858</fpage>&#x2013;<lpage>3868</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.11.092</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertassoni</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Cecconi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Manoharan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Nikkhah</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hjortnaes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cristino</surname>
<given-names>A. L.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Hydrogel Bioprinted Microchannel Networks for Vascularization of Tissue Engineering Constructs</article-title>. <source>Lab. Chip</source> <volume>14</volume>, <fpage>2202</fpage>&#x2013;<lpage>2211</lpage>. <pub-id pub-id-type="doi">10.1039/c4lc00030g</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharjee</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zehnder</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Rowe</surname>
<given-names>K. G.</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nixon</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Sawyer</surname>
<given-names>W. G.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Writing in the Granular Gel Medium</article-title>. <source>Sci. Adv.</source> <volume>25</volume>, <fpage>e1500655</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.1500655</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bursac</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Juhas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rando</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Synergizing Engineering and Biology to Treat and Model Skeletal Muscle Injury and Disease</article-title>. <source>Annu. Rev. Biomed. Eng.</source> <volume>17</volume>, <fpage>217</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-bioeng-071114-040640</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buyse</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Van Der Mieren</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Erb</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>D&#x27;hooge</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Herijgers</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Verbeken</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Long-term Blinded Placebo-Controlled Study of SNT-MC17/idebenone in the Dystrophin Deficient Mdx Mouse: Cardiac protection and Improved Exercise Performance</article-title>. <source>Eur. Heart J.</source> <volume>30</volume>, <fpage>116</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehn406</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>R. Z.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bursac</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Exercise Mimetics and JAK Inhibition Attenuate IFN-&#x3b3;-Induced Wasting in Engineered Human Skeletal Muscle</article-title>. <source>Sci. Adv.</source> <volume>7</volume>, <fpage>4</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abd9502</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>H.-G.</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A 3D Cell Printed Muscle Construct with Tissue-Derived Bioink for the Treatment of Volumetric Muscle Loss</article-title>. <source>Biomaterials</source> <volume>206</volume>, <fpage>160</fpage>&#x2013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.03.036</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>H.-G.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>3D Cell Printing of Functional Skeletal Muscle Constructs Using Skeletal Muscle-Derived Bioink</article-title>. <source>Adv. Healthc. Mater.</source> <volume>5</volume>, <fpage>2636</fpage>&#x2013;<lpage>2645</lpage>. <pub-id pub-id-type="doi">10.1002/adhm.201600483</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christensen</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Von Halling Laier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kiziltay</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>N. B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>3D Printed Hydrogel Multiassay Platforms for Robust Generation of Engineered Contractile Tissues</article-title>. <source>Biomacromolecules</source> <volume>21</volume>, <fpage>356</fpage>&#x2013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biomac.9b01274</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clemens</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Mah</surname>
<given-names>J.&#x20;K.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>E. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping</article-title>. <source>JAMA Neurol.</source> <volume>77</volume>, <fpage>982</fpage>&#x2013;<lpage>991</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2020.1264</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Compton</surname>
<given-names>B. G.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>3D-Printing of Lightweight Cellular Composites</article-title>. <source>Adv. Mater.</source> <volume>26</volume>, <fpage>5930</fpage>&#x2013;<lpage>5935</lpage>. <pub-id pub-id-type="doi">10.1002/adma.201401804</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Csapo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gumpenberger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wessner</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Skeletal Muscle Extracellular Matrix - what Do We Know about its Composition, Regulation, and Physiological Roles? A Narrative Review</article-title>. <source>Front. Physiol.</source> <volume>11</volume>, <fpage>253</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2020.00253</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cvetkovic</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rich</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Raman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bashir</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A 3D-Printed Platform for Modular Neuromuscular Motor Units</article-title>. <source>Microsyst. Nanoeng</source> <volume>3</volume>, <fpage>17015</fpage>&#x2013;<lpage>17019</lpage>. <pub-id pub-id-type="doi">10.1038/micronano.2017.15</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daly</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Pitacco</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nulty</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cunniffe</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>3D Printed Microchannel Networks to Direct Vascularisation during Endochondral Bone Repair</article-title>. <source>Biomaterials</source> <volume>162</volume>, <fpage>34</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.01.057</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.-W.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>J.-S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Decellularized Extracellular Matrix Bioinks and the External Stimuli to Enhance Cardiac Tissue Development <italic>In Vitro</italic>
</article-title>. <source>Acta Biomater.</source> <volume>95</volume>, <fpage>188</fpage>&#x2013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2019.04.026</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dixon</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jose</surname>
<given-names>R. R.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Bioinspired Three-Dimensional Human Neuromuscular Junction Development in Suspended Hydrogel Arrays</article-title>. <source>Tissue Eng. C: Methods</source> <volume>24</volume>, <fpage>346</fpage>&#x2013;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tec.2018.0062</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eken</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Elder</surname>
<given-names>G. C. B.</given-names>
</name>
<name>
<surname>L&#xf8;mo</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Development of Tonic Firing Behavior in Rat Soleus Muscle</article-title>. <source>J.&#x20;Neurophysiol.</source> <volume>99</volume>, <fpage>1899</fpage>&#x2013;<lpage>1905</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00834.2007</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engler</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bo&#x308;nnemann</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Discher</surname>
<given-names>D. E.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Myotubes Differentiate Optimally on Substrates with Tissue-like Stiffness</article-title>. <source>J.&#x20;Cel. Biol.</source> <volume>166</volume>, <fpage>877</fpage>&#x2013;<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200405004</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flynn</surname>
<given-names>L. E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The Use of Decellularized Adipose Tissue to Provide an Inductive Microenvironment for the Adipogenic Differentiation of Human Adipose-Derived Stem Cells</article-title>. <source>Biomaterials</source> <volume>31</volume>, <fpage>4715</fpage>&#x2013;<lpage>4724</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2010.02.046</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Schnell</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Akana</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>El-Husayni</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Desjardins</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Increased Dystrophin Production with Golodirsen in Patients with Duchenne Muscular Dystrophy</article-title>. <source>Neurology</source> <volume>94</volume>, <fpage>e2270</fpage>&#x2013;<lpage>e2282</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000009233</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Combination of Inflammation-Related Cytokines Promotes Long-Term Muscle Stem Cell Expansion</article-title>. <source>Cell Res.</source> <volume>25</volume>, <fpage>655</fpage>&#x2013;<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2015.58</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furberg</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Pitt</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Withdrawal of Cerivastatin from the World Market</article-title>. <source>Curr. Control. Trials Cardiovasc. Med.</source> <volume>2</volume>, <fpage>205</fpage>. <pub-id pub-id-type="doi">10.1186/cvm-2-5-205</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.&#x20;Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>B. W.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Tissue-engineering of Vascular Grafts Containing Endothelium and Smooth-Muscle Using Triple-Coaxial Cell Printing</article-title>. <source>Appl. Phys. Rev.</source> <volume>6</volume>, <fpage>041402</fpage>. <pub-id pub-id-type="doi">10.1063/1.5099306</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B. S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Tissue Engineered Bio-Blood-Vessels Constructed Using a Tissue-specific Bioink and 3D Coaxial Cell Printing Technique: A Novel Therapy for Ischemic Disease</article-title>. <source>Adv. Funct. Mater.</source> <volume>27</volume>, <fpage>1</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1002/adfm.201700798</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>W. W.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Construction of a Novel <italic>In Vitro</italic> Atherosclerotic Model from Geometry-Tunable Artery Equivalents Engineered via in-Bath Coaxial Cell Printing</article-title>. <source>Adv. Funct. Mater.</source> <volume>31</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/adfm.202008878</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert-Honick</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Somers</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Lovering</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>H.-Q.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Engineering Functional and Histological Regeneration of Vascularized Skeletal Muscle</article-title>. <source>Biomaterials</source> <volume>164</volume>, <fpage>70</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.02.006</pub-id> </citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grady</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nichol</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Cunningham</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>R. S..</given-names>
</name>
<name>
<surname>Sanes</surname>
<given-names>J. R.</given-names>
</name>
<etal/>
</person-group> (<year>1997</year>). <article-title>Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy</article-title>. <source>Cell</source> <volume>90</volume>, <fpage>729</fpage>&#x2013;<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80533-4</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grosberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alford</surname>
<given-names>P. W.</given-names>
</name>
<name>
<surname>McCain</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>K. K.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Ensembles of Engineered Cardiac Tissues for Physiological and Pharmacological Study: Heart on a Chip</article-title>. <source>Lab. Chip</source> <volume>11</volume>, <fpage>4165</fpage>&#x2013;<lpage>4173</lpage>. <pub-id pub-id-type="doi">10.1039/C1LC20557A</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinds</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Dennis</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Bursac</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The Role of Extracellular Matrix Composition in Structure and Function of Bioengineered Skeletal Muscle</article-title>. <source>Biomaterials</source> <volume>32</volume>, <fpage>3575</fpage>&#x2013;<lpage>3583</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2011.01.062</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinton</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Jallerat</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Palchesko</surname>
<given-names>R. N.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Grodzicki</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Shue</surname>
<given-names>H. J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Three-dimensional Printing of Complex Biological Structures by Freeform Reversible Embedding of Suspended Hydrogels</article-title>. <source>Sci. Adv.</source> <volume>1</volume>, <fpage>e1500758</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.1500758</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>A Compound Scaffold with Uniform Longitudinally Oriented Guidance Cues and a Porous Sheath Promotes Peripheral Nerve Regeneration <italic>In Vivo</italic>
</article-title>. <source>Acta Biomater.</source> <volume>68</volume>, <fpage>223</fpage>&#x2013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2017.12.010</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwangbo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Roh</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Joshi</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>S. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Bone Tissue Engineering via Application of a Collagen/hydroxyapatite 4D-Printed Biomimetic Scaffold for Spinal Fusion</article-title>. <source>Appl. Phys. Rev.</source> <volume>8</volume>, <fpage>021403</fpage>. <pub-id pub-id-type="doi">10.1063/5.0035601</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isaac</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Usas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Dystrophin and Utrophin &#x201c;Double Knockout&#x201d; Dystrophic Mice Exhibit a Spectrum of Degenerative Musculoskeletal Abnormalities</article-title>. <source>J.&#x20;Orthop. Res.</source> <volume>31</volume>, <fpage>343</fpage>&#x2013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1002/jor.22236</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishii</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mabuchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sekiya</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sekiguchi</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Recapitulation of Extracellular LAMININ Environment Maintains Stemness of Satellite Cells <italic>In Vitro</italic>
</article-title>. <source>Stem Cel Rep.</source> <volume>10</volume>, <fpage>568</fpage>&#x2013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2017.12.013</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shahriari</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Back</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Functional Skeletal Muscle Regeneration with Thermally Drawn Porous Fibers and Reprogrammed Muscle Progenitors for Volumetric Muscle Injury</article-title>. <source>Adv. Mater.</source> <volume>33</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/adma.202007946</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Judson</surname>
<given-names>R. N.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>F. M. V.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Towards Stem Cell Therapies for Skeletal Muscle Repair</article-title>. <source>NPJ&#x20;Regen. Med.</source> <volume>5</volume>, <fpage>10</fpage>. <pub-id pub-id-type="doi">10.1038/s41536-020-0094-3</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juhas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Abutaleb</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.&#x20;T.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sriworarat</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Incorporation of Macrophages into Engineered Skeletal Muscle Enables Enhanced Muscle Regeneration</article-title>. <source>Nat. Biomed. Eng.</source> <volume>2</volume>, <fpage>942</fpage>&#x2013;<lpage>954</lpage>. <pub-id pub-id-type="doi">10.1038/s41551-018-0290-2</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>H.-W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>I. K.</given-names>
</name>
<name>
<surname>Kengla</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Atala</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>A 3D Bioprinting System to Produce Human-Scale Tissue Constructs with Structural Integrity</article-title>. <source>Nat. Biotechnol.</source> <volume>34</volume>, <fpage>312</fpage>&#x2013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3413</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khodabukus</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Baar</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Defined Electrical Stimulation Emphasizing Excitability for the Development and Testing of Engineered Skeletal Muscle</article-title>. <source>Tissue Eng. Part C: Methods</source> <volume>18</volume>, <fpage>349</fpage>&#x2013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tec.2011.0364</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khodabukus</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Madden</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Prabhu</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Koves</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Jackman</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Muoio</surname>
<given-names>D. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Electrical Stimulation Increases Hypertrophy and Metabolic Flux in Tissue-Engineered Human Skeletal Muscle</article-title>. <source>Biomaterials</source> <volume>198</volume>, <fpage>259</fpage>&#x2013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.08.058</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>D. W.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Light&#x2010;Activated Decellularized Extracellular Matrix&#x2010;Based Bioinks for Volumetric Tissue Analogs at the Centimeter Scale</article-title>. <source>Adv. Funct. Mater.</source> <volume>31</volume>, <fpage>2011252</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.202011252</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.-C.</given-names>
</name>
<name>
<surname>Asada</surname>
<given-names>H. H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Extracellular Matrix Remodelling Induced by Alternating Electrical and Mechanical Stimulations Increases the Contraction of Engineered Skeletal Muscle Tissues</article-title>. <source>Sci. Rep.</source> <volume>9</volume>, <fpage>2732</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-39522-6</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Seol</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>I. K.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Atala</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Neural Cell Integration into 3D Bioprinted Skeletal Muscle Constructs Accelerates Restoration of Muscle Function</article-title>. <source>Nat. Commun.</source> <volume>11</volume>, <fpage>1025</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-14930-9</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>G. H.</given-names>
</name>
</person-group> (<year>2018a</year>). <article-title>3D-Printed Biomimetic Scaffold Simulating Microfibril Muscle Structure</article-title>. <source>Adv. Funct. Mater.</source> <volume>28</volume>, <fpage>1800405</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.201800405</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Seol</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>I. K.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H. W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<etal/>
</person-group> (<year>2018b</year>). <article-title>3D Bioprinted Human Skeletal Muscle Constructs for Muscle Function Restoration</article-title>. <source>Sci. Rep.</source> <volume>8</volume>, <fpage>12307</fpage>&#x2013;<lpage>12315</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-29968-5</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>G. H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A Myoblast-Laden Collagen Bioink with Fully Aligned Au Nanowires for Muscle-Tissue Regeneration</article-title>. <source>Nano Lett.</source> <volume>19</volume>, <fpage>8612</fpage>&#x2013;<lpage>8620</lpage>. <pub-id pub-id-type="doi">10.1021/acs.nanolett.9b03182</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A Functional Bioink and its Application in Myoblast Alignment and Differentiation</article-title>. <source>Chem. Eng. J.</source> <volume>366</volume>, <fpage>150</fpage>&#x2013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/j.cej.2019.02.071</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Atala</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Efficient Myotube Formation in 3D Bioprinted Tissue Construct by Biochemical and Topographical Cues</article-title>. <source>Biomaterials</source> <volume>230</volume>, <fpage>119632</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.119632</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolesky</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Homan</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Skylar-Scott</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Three-dimensional Bioprinting of Thick Vascularized Tissues</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source> <volume>113</volume>, <fpage>3179</fpage>&#x2013;<lpage>3184</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1521342113</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>H. G.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Promoting Long&#x2010;Term Cultivation of Motor Neurons for 3D Neuromuscular Junction Formation of 3D <italic>In Vitro</italic> Using Central&#x2010;Nervous&#x2010;Tissue&#x2010;Derived Bioink</article-title>. <source>Adv. Healthc. Mater.</source> <volume>10</volume>, <fpage>2100581</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.202100581</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuschel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yablonka-Reuveni</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bornemann</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Satellite Cells on Isolated Myofibers from normal and Denervated Adult Rat Muscle</article-title>. <source>J.&#x20;Histochem. Cytochem.</source> <volume>47</volume>, <fpage>1375</fpage>&#x2013;<lpage>1383</lpage>. <pub-id pub-id-type="doi">10.1177/002215549904701104</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Shiwarski</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Tashman</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Hinton</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Yerneni</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>3D Bioprinting of Collagen to Rebuild Components of the Human Heart</article-title>. <source>Science</source> <volume>365</volume>, <fpage>482</fpage>&#x2013;<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1126/science.aav9051</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.&#x20;B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.-H.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>J.-K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.-S.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>Y. M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Microchannel Network Hydrogel Induced Ischemic Blood Perfusion Connection</article-title>. <source>Nat. Commun.</source> <volume>11</volume>, <fpage>615</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-14480-0</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Mohiuddin</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Engineered Heterochronic Parabiosis in 3D Microphysiological System for Identification of Muscle Rejuvenating Factors</article-title>. <source>Adv. Funct. Mater.</source> <volume>30</volume>, <fpage>2002924</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.202002924</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madden</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Juhas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>W. E.</given-names>
</name>
<name>
<surname>Truskey</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Bursac</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Bioengineered Human Myobundles Mimic Clinical Responses of Skeletal Muscle to Drugs</article-title>. <source>ELife</source> <volume>4</volume>, <fpage>e04885</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.04885</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maffioletti</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Sarcar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>A. B. H.</given-names>
</name>
<name>
<surname>Mannhardt</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pinton</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Moyle</surname>
<given-names>L. A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering</article-title>. <source>Cel Rep.</source> <volume>23</volume>, <fpage>899</fpage>&#x2013;<lpage>908</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.091</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcinczyk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Elmashhady</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Talovic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bugis</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Laminin-111 Enriched Fibrin Hydrogels for Skeletal Muscle Regeneration</article-title>. <source>Biomaterials</source> <volume>141</volume>, <fpage>233</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.07.003</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Integrins: Redundant or Important Players in Skeletal Muscle</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>278</volume>, <fpage>14587</fpage>&#x2013;<lpage>14590</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R200022200</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGreevy</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Hakim</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>McIntosh</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Animal Models of Duchenne Muscular Dystrophy: From Basic Mechanisms to Gene Therapy</article-title>. <source>Dis. Model. Mech.</source> <volume>8</volume>, <fpage>195</fpage>&#x2013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.018424</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>D.-H. T.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>D. M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Rapid Casting of Patterned Vascular Networks for Perfusable Engineered Three-Dimensional Tissues</article-title>. <source>Nat. Mater</source> <volume>11</volume>, <fpage>768</fpage>&#x2013;<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1038/nmat3357</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morimoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kato-Negishi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Onoe</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Three-dimensional Neuron-Muscle Constructs with Neuromuscular Junctions</article-title>. <source>Biomaterials</source> <volume>34</volume>, <fpage>9413</fpage>&#x2013;<lpage>9419</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.08.062</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morimoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Onoe</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Biohybrid Robot with Skeletal Muscle Tissue Covered with a Collagen Structure for Moving in Air</article-title>. <source>APL Bioeng.</source> <volume>4</volume>, <fpage>026101</fpage>. <pub-id pub-id-type="doi">10.1063/1.5127204</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mozetic</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Giannitelli</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Gori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Trombetta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rainer</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Engineering Muscle Cell Alignment through 3D Bioprinting</article-title>. <source>J.&#x20;Biomed. Mater. Res.</source> <volume>105</volume>, <fpage>2582</fpage>&#x2013;<lpage>2588</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.36117</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nesmith</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Pasqualini</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>O&#x2019;Connor</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Pincus</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>August</surname>
<given-names>P. R.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>A Human <italic>In Vitro</italic> Model of Duchenne Muscular Dystrophy Muscle Formation and Contractility</article-title>. <source>J.&#x20;Cel Biol.</source> <volume>215</volume>, <fpage>47</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201603111</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neufeld</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yeini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Reisman</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shtilerman</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ben-Shushan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pozzi</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Microengineered Perfusable 3D-Bioprinted Glioblastoma Model for <italic>In Vivo</italic> Mimicry of Tumor Microenvironment</article-title>. <source>Sci. Adv.</source> <volume>7</volume>, <fpage>1</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abi9119</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikoli&#x107;</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Skaret Bakke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tranheim Kase</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rudberg</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Flo Halle</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rustan</surname>
<given-names>A. C.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Electrical Pulse Stimulation of Cultured Human Skeletal Muscle Cells as an <italic>In Vitro</italic> Model of Exercise</article-title>. <source>PLoS ONE</source> <volume>7</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033203</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nowak</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>K. E.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Duchenne Muscular Dystrophy and Dystrophin: Pathogenesis and Opportunities for Treatment</article-title>. <source>EMBO Rep.</source> <volume>5</volume>, <fpage>872</fpage>&#x2013;<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1038/sj.embor.7400221</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sivathanu</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kamm</surname>
<given-names>R. D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Crosstalk between Developing Vasculature and Optogenetically Engineered Skeletal Muscle Improves Muscle Contraction and Angiogenesis</article-title>. <source>Biomaterials</source> <volume>156</volume>, <fpage>65</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.11.041</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Smiley</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vandenburgh</surname>
<given-names>H. H.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Mechanical Stimulation Improves Tissue-Engineered Human Skeletal Muscle</article-title>. <source>Am. J.&#x20;Physiology-Cell Physiol.</source> <volume>283</volume>, <fpage>C1557</fpage>&#x2013;<lpage>C1565</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00595.2001</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quarta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brett</surname>
<given-names>J.&#x20;O.</given-names>
</name>
<name>
<surname>DiMarco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>De Morree</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boutet</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Chacon</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>An Artificial Niche Preserves the Quiescence of Muscle Stem Cells and Enhances Their Therapeutic Efficacy</article-title>. <source>Nat. Biotechnol.</source> <volume>34</volume>, <fpage>752</fpage>&#x2013;<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3576</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quarta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cromie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chacon</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Blonigan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Akimenko</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Bioengineered Constructs Combined with Exercise Enhance Stem Cell-Mediated Treatment of Volumetric Muscle Loss</article-title>. <source>Nat. Commun.</source> <volume>8</volume>, <fpage>15613</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms15613</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redd</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Zeinstra</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Martinson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Patterned Human Microvascular Grafts Enable Rapid Vascularization and Increase Perfusion in Infarcted Rat Hearts</article-title>. <source>Nat. Commun.</source> <volume>10</volume>, <fpage>584</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-08388-7</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Relaix</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bencze</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Borok</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Der Vartanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gattazzo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mademtzoglou</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Perspectives on Skeletal Muscle Stem Cells</article-title>. <source>Nat. Commun.</source> <volume>12</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-20760-6</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwab</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Levato</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>D&#x2019;Este</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Piluso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Eglin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Malda</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Printability and Shape Fidelity of Bioinks in 3D Bioprinting</article-title>. <source>Chem. Rev.</source> <volume>120</volume>, <fpage>11028</fpage>&#x2013;<lpage>11055</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.0c00084</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serena</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zatti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zoso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lo Verso</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tedesco</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Cossu</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts&#x27; Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model</article-title>. <source>Med.</source> <volume>5</volume>, <fpage>1676</fpage>&#x2013;<lpage>1683</lpage>. <pub-id pub-id-type="doi">10.5966/sctm.2015-0053</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharples</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Player</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>N. R. W.</given-names>
</name>
<name>
<surname>Mudera</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Modellingin Vivoskeletal Muscle Ageingin Vitrousing Three-Dimensional Bioengineered Constructs</article-title>. <source>Aging Cell.</source> <volume>11</volume>, <fpage>986</fpage>&#x2013;<lpage>995</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2012.00869.x</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skylar-Scott</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Uzel</surname>
<given-names>S. G. M.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Ahrens</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Truby</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Damaraju</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Biomanufacturing of Organ-specific Tissues with High Cellular Density and Embedded Vascular Channels</article-title>. <source>Sci. Adv.</source> <volume>5</volume>, <fpage>eaaw2459</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.aaw2459</pub-id> </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarum</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Folkesson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Atherton</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Kadi</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Electrical Pulse Stimulation: Anin Vitroexercise Model for the Induction of Human Skeletal Muscle Cell Hypertrophy. A Proof-Of-Concept Study</article-title>. <source>Exp. Physiol.</source> <volume>102</volume>, <fpage>1405</fpage>&#x2013;<lpage>1413</lpage>. <pub-id pub-id-type="doi">10.1113/EP086581</pub-id> </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tedesco</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Cossu</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Stem Cell Therapies for Muscle Disorders</article-title>. <source>Curr. Opin. Neurol.</source> <volume>25</volume>, <fpage>597</fpage>&#x2013;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0b013e328357f288</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uygun</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Soto-Gutierrez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yagi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Izamis</surname>
<given-names>M.-L.</given-names>
</name>
<name>
<surname>Guzzardi</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Organ Reengineering through Development of a Transplantable Recellularized Liver Graft Using Decellularized Liver Matrix</article-title>. <source>Nat. Med.</source> <volume>16</volume>, <fpage>814</fpage>&#x2013;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2170</pub-id> </citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallat</surname>
<given-names>J.-M.</given-names>
</name>
<name>
<surname>Mathis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Funalot</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The Various Charcot-Marie-Tooth Diseases</article-title>. <source>Curr. Opin. Neurol.</source> <volume>26</volume>, <fpage>473</fpage>&#x2013;<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0b013e328364c04b</pub-id> </citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Westerga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gramsbergen</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Development of the EMG of the Soleus Muscle in the Rat</article-title>. <source>Develop. Brain Res.</source> <volume>80</volume>, <fpage>233</fpage>&#x2013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/0165-3806(94)90108-2</pub-id> </citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rudnicki</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Satellite Cells and the Muscle Stem Cell Niche</article-title>. <source>Physiol. Rev.</source> <volume>93</volume>, <fpage>23</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00043.2011</pub-id> </citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Arneri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bersini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>S.-R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Goli-Malekabadi</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Bioprinting 3D Microfibrous Scaffolds for Engineering Endothelialized Myocardium and Heart-On-A-Chip</article-title>. <source>Biomaterials</source> <volume>110</volume>, <fpage>45</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.09.003</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>